A Collection of Designed Peptides to Target SARS-CoV-2 Spike RBD—ACE2 Interaction
The angiotensin-converting enzyme 2 (ACE2) is the receptor used by SARS-CoV and SARS-CoV-2 coronaviruses to attach to cells via the receptor-binding domain (RBD) of their viral spike protein. Since the start of the COVID-19 pandemic, several structures of protein complexes involving ACE2 and RBD as...
Saved in:
Main Authors: | Narcis Fernandez-Fuentes, Ruben Molina, Baldo Oliva |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7f0fa4f75a5e4b008d3c0c40882c1a0a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
by: Michael I Barton, et al.
Published: (2021) -
Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection
by: Fengling Feng, et al.
Published: (2021) -
Presencia y Expresión del Receptor ACE2 (Target de SARS-CoV-2) en Tejidos Humanos y Cavidad Oral. Posibles Rutas de Infección en Órganos Orales
by: Pastrian-Soto,Gabriel
Published: (2020) -
Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in <i>Nicotiana benthamiana</i> Plant as a Vaccine Candidate against COVID-19
by: Tarlan Mamedov, et al.
Published: (2021) -
Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction
by: Balkrishna A, et al.
Published: (2021)